Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0030 for an unrestricted procurement for Calcitonin Gene-Related Peptides (CGRP), for t... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79724R0030 for an unrestricted procurement for Calcitonin Gene-Related Peptides (CGRP), for the Department of Veterans Affairs (VA) (inclusive of Consolidated Mail Order Pharmacies (CMOPs) and Option 2 State Veterans Homes (SVH)), Indian Health Service (IHS), and Federal Health Care Center (FHCC). VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. The successful offeror/contractor's label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Solicitation #36E79724R0030 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 10, 2024, with a tentative closing date of October 24, 2024. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check Contracting Opportunities at SAM.gov for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to Christopher.Carthro@va.gov. The estimated annual requirements are as follows: OFFERORS MUST MAKE ALL PACKAGE SIZES COMMERCIALLY AVAILABLE AT THE SAME PRICE PER DOSE ITEM DESCRIPTION PACKAGE SIZE (DOSES) NUMBER OF DOSES PER YEAR VA TOTAL NUMBER OF PATEINTS PER YEAR IHS TOTAL NUMBER OF PATIENTS PER YEAR 1a* ERENUMAB-AOOE 70MG/ML AUTOINJECTOR,1ML 1 12 11,861 828 AND AND 1b* ERENUMAB-AOOE 140MG/ML AUTOINJECTOR,1ML 1 OR OR 2a* FREMANEZUMAB-VFRM 225MG/1.5ML INJ,SYRINGE,1.5ML 1 12 11,861 828 AND AND 2b* FREMANEZUMAB-VFRM 225MG/1.5ML AUTOINJECTOR 1 OR OR 3a* GALCANEZUMAB-GNLM 120MG/ML INJ,PEN,1ML 1 13 11,861 828 AND AND 3b* GALCANEZUMAB-GNLM 120MG/ML INJ,SYRINGE,1ML 1 AGENCY # OF PATIENTS/YEAR VA 11,861 IHS 828